Paper370588
The Marfan syndrome: diagnosis and management.
Pyeritz RE and 1 other. N Engl J Med, 1979. Cited by 711 papers, by iCite.
Cite this record
ConductScience Library. The Marfan syndrome: diagnosis and management. Papers, record 370588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/370588
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Marfan Syndrome | Major topic |
| Adult | |
| Bone Diseases | |
| Child | |
| Child, Preschool | |
| Estrogens | |
| Eye Diseases | |
| Eye Manifestations | |
| Female | |
| Genetic Counseling | |
| Heart Valve Diseases | |
| Humans | |
| Lung Diseases | |
| Pregnancy | |
| Pregnancy Complications | |
| Progestins | |
| Risk |
Source PubMed
Cited by180
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 711 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42752801 | Introducing Allopurinol to the Medical Treatment of Marfan Syndrome: Advantages, Limitations, and Potential Extension to other Aortopathies. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/42752801 | PubMed |
| 42648118 | Generation of two induced pluripotent stem cell lines from Marfan syndrome patients carrying FBN1 mutations. | Stem Cell Res | 2026 | https://conductscience.org/library/papers/42648118 | PubMed |
| 42544580 | Lymphatic therapies open the valve in Marfan syndrome. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42544580 | PubMed |
| 42186038 | A novel NYX gene mutation identified in a Chinese Northeast Han family with high myopia and night blindness. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42186038 | PubMed |
| 39465402 | Mitral Annular Disjunction Associated with Ventricular Dilation in Pediatric Marfan Syndrome: A Cardiovascular Magnetic Resonance Study. | Pediatr Cardiol | 2025 | https://conductscience.org/library/papers/39465402 | PubMed |
| 39062663 | Somatic Variants Acquired Later in Life Associated with Thoracic Aortic Aneurysms: JAK2 V617F. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39062663 | PubMed |
| 38958168 | Targeted next-generation sequencing reveals the genetic mechanism of Chinese Marfan syndrome cohort with ocular manifestation. | Mol Genet Genomic Med | 2024 | https://conductscience.org/library/papers/38958168 | PubMed |
| 38737133 | Incidence and Outcomes of Aortic Dissection in Tabriz, Iran; a Longitudinal Study of 150 Cases. | Arch Acad Emerg Med | 2024 | https://conductscience.org/library/papers/38737133 | PubMed |
| 38487153 | Frequency of Cardiac Valvulopathies in Patients With Marfan Syndrome: A Systematic Review and Meta-Analysis. | Cureus | 2024 | https://conductscience.org/library/papers/38487153 | PubMed |
| 38427739 | Genetic determinants of blood pressure and heart rate identified through ENU-induced mutagenesis with automated meiotic mapping. | Sci Adv | 2024 | https://conductscience.org/library/papers/38427739 | PubMed |
| 38036736 | Aortic aneurysms: current pathogenesis and therapeutic targets. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/38036736 | PubMed |
| 37868874 | Minimally invasive repair of pectus excavatum in adults: a review article of presentation, workup, and surgical treatment. | J Thorac Dis | 2023 | https://conductscience.org/library/papers/37868874 | PubMed |
| 37684520 | A population-based survey of FBN1 variants in Iceland reveals underdiagnosis of Marfan syndrome. | Eur J Hum Genet | 2024 | https://conductscience.org/library/papers/37684520 | PubMed |
| 37475058 | Multi-omics in thoracic aortic aneurysm: the complex road to the simplification. | Cell Biosci | 2023 | https://conductscience.org/library/papers/37475058 | PubMed |
| 37443678 | Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37443678 | PubMed |
| 37160466 | Prophylactic effect of angiotensin receptor blockers in children with genetic aortopathies: the early bird catches the worm. | Clin Res Cardiol | 2023 | https://conductscience.org/library/papers/37160466 | PubMed |
| 36950300 | Assessment of shape-based features ability to predict the ascending aortic aneurysm growth. | Front Physiol | 2023 | https://conductscience.org/library/papers/36950300 | PubMed |
| 36577770 | Endothelial dysfunction in Marfan syndrome mice is restored by resveratrol. | Sci Rep | 2022 | https://conductscience.org/library/papers/36577770 | PubMed |
| 36140728 | Case Reports of Aortic Aneurism in Fragile X Syndrome. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36140728 | PubMed |
| 35908146 | Surgical outcome of scoliosis in patients with Marfan syndrome. | Spine Deform | 2022 | https://conductscience.org/library/papers/35908146 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/370588
GET https://conductscience.org/api/papers/v1/370588/cited_by?page=2